Chemometric analysis of chromatographic data in stability investigation of cephalosporins

• Autorzy: Dąbrowska M. , Komsta Ł. , Opoka W. , Starek M.

Identyfikatory

DOI

10.1556/1326.2017.00341

• Języki publikacji: EN

Abstrakty

EN

The specific aim of this investigation was to study the kinetics of the degradation of cefazolin, cefaclor, cefuroxime axetil, and cefepime in aqueous solution, in the presence (or absence) of various redox agents (iodine solution, potassium permanganate, hydrogen peroxide, sodium thiosulfate, and ascorbic acid) as a function of temperature. Various factors, such as concentration of the analyzed compounds and redox agents, storage time, and temperature, were analyzed. The degradation process of chosen antibiotics was observed chromatographically and fitted to the kinetic models, obtaining model parameters (k, t0.1, t0.5). Principal component analysis (PCA), parallel factor analysis (PARAFAC), and hierarchical cluster analysis (HCA) methods were carried out to interpret the dependencies between these factors on the drug stability.

Słowa kluczowe

EN

Cephalosporin; redox agents; degradation process; chemometrics

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2018
• Tom: Vol. 30, no. 4
• Strony: 255--263
• Opis fizyczny: Bibliogr. 56 poz., rys.

Twórcy

autor

Dąbrowska M.

• Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688 Krakow, Poland

autor

Komsta Ł.

• Department of Medicinal Chemistry, Medical University of Lublin, 4 Jaczewskiego St, 20 090 Lublin, Poland

autor

Opoka W.

• Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688 Krakow, Poland

autor

Starek M.

• Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688 Krakow, Poland

Bibliografia

• [1] Karchmer A. W. In Principles and Practice of Antiinfectious Disease MandellG. L.; Bennett J. E.; Dolin R., Eds.; Churchill Livingstone: Philadelphia, PA, USA, 2000.
• [2] Fagerquist C. K.; Lightfield A. R.; Lehotay S. J. Anal. Chem. 2005, 77, 1473.
• [3] Rao R. N.; Venkateswarlu N.; NarsimhaR. J. Chromatogr. A 2008, 1187, 151.
• [4] Dasenbrock C. O.; La CourseW. R. Anal. Chem. 1998, 70, 2415.
• [5] Baranowska I.; Markowski P.; Baranowski J. Anal. Sci. 2009, 25, 1307.
• [6] Denooz R.; Charlier C. J. Chromatogr. B 2008, 864, 161.
• [7] Dąbrowska M.; Starek M. In TLC of β-Lactam Antibiotic. Thin Layer Chromatography in Drug Analysis KomstaŁ.; Waksmundzka-HajnosM.; ShermaJ., Eds.; Chromatographic Science Series, CRC Press Taylor & Francis Comp.: New York, USA, 2012.
• [8] Verdier M-C.; Tribut O.; Tattevin P.; Le TulzoY.; Michelet Ch.; Bentue-FerrerD. Antimicrob. Agents Chemother. 2011, 55, 4873.
• [9] Nemutlu E.; Kır S.; Katlan D.; Beksac M. S. Talanta, 2009, 80, 117.
• [10] Krzek J.; Dąbrowska M. Chromatographia 2003, 58, 231.
• [11] Dąbrowska M.; Krzek J. J. Planar Chromatogr. 2010, 23, 1.
• [12] Dąbrowska M.; Starek M.; Pikulska S. J. Planar Chromatogr. 2011, 24, 23.
• [13] Dąbrowska M.; Krzek J.; Miękina E. J. Planar Chromatogr. 2012, 25, 127.
• [14] Singh D. K.; Maheshwari G. Biomed. Chromatogr. 2010, 24, 1084.
• [15] Dąbrowska M.; Starek M.; Krzek J.; Papp E.; Król P. Biomed. Chromatogr. 2015, 29, 388.
• [16] Kohanski M. A.; Dwyer D. J.; Wierzbowski J.; Cottarel G.; Collins J. J. Cell, 2008, 135, 679.
• [17] Kohanski M. A.; Dwyer D. J.; Hayete B.; Lawrence C. A.; Collins J. J. Cell, 2007, 130, 797.
• [18] Kohanski M. A.; De Pristo M. A.; Collins J. J. Mol. Cell 2010, 37, 311.
• [19] Dwyer D. J.; Kohanski M. A.; Collins J. J. Curr. Opin. Microbiol. 2009, 12, 482.
• [20] Liu Y.; Imlay J. A. Science 2013, 339, 1210.
• [21] Keren I.; Wu Y.; Inocencio J.; Mulcahy L. R.; Lewis K. Science 2013, 339, 1213.
• [22] Brynildsen M. P.; Winkler J. A.; Spina C. S.; Mac Donald I. C.; Collins J. J. Nat. Biotechnol. 2013, 31, 160.
• [23] Djoric D.; Kristich Ch. J. Antimicrob. Agents Chemother. 2015, 59, 159.
• [24] HotaS. K.; Barhwal K.; Ray K.; Singh S. B.; IlavazhaganG. Neurobiol. Learn Mem. 2008, 89, 522.
• [25] KojimaR.; ItoM.; SuzukiY. Jpn. J. Pharmacol. 1989, 51, 465.
• [26] YılmazN.; IlhanS.; NazırogluM.; OktarS.; NacarA.; ArıcaV.; TutancM. Cell Biochem. Funct. 2011, 29, 102.
• [27] FDA, Draft Guidance for Industry: Stability Testing of Drug Substances and Drug Products, FDA, Rockville, MD, 1998.
• [28] International Conference on Harmonisation (ICH), Guidance for Industry, Q1A(R2): Stability Testing of New Drug Substances and Products, IFPMA, Geneva, 2000.
• [29] Carstensen J. T.; Rhodes C. T. Drug stability, principles and practices Marcel Decer Inc.: New York, USA, 2000.
• [30] Singh I.; Juneja P.; Kaur B.; Kumar P. ISRN Anal. Chem. 2013, 13, 3.
• [31] Stasiak J.; Koba M.; Baczek T.; Bucinski A. Med. Chem. 2015, 11, 432.
• [32] Evans P.; Persaud K. C.; Mcneish A. S.; Sneath R. W.; Hobson N.; Magan N. Sensor Actuat. B-Chem. 2000, 69, 348.
• [33] Cen H.; He Y. Trends. Food Sci. Tech. 2007, 18, 72.
• [34] DiC. Z.; Crainiceanu C. M.; Caffo B. S.; Punjabi N. M. Ann. Appl. Stat. 2009, 3, 458.
• [35] Huang S. Y.; Yeh Y. R.; Eguchi S. Neural Comput. 2009, 21, 3179.
• [36] Mariey L.; Signolle J.; Amiel C.; Travert J. Vib. Spectrosc. 2001, 26, 151.
• [37] Costello A.; Osborne J. Pract. Ass. Res. Eval. 2005, 10, 1.
• [38] Ivosev G.; Burton L.; Bonner R. Anal. Chem. 2008, 80, 4933.
• [39] Smit S.; Breemen M. J.; Hoefsloot H. C. J.; Aerts J. M. F. G.; Koster C. G.; Smilde A. K. Anal. Chim. Acta 2007, 592, 210.
• [40] Jolliffe I. T. Principal Component Analysis; Springer: New York, USA, 2002.
• [41] Wentzell P. D.; Andrews D. T.; Hamilton D. C.; Faber K.; Kowalski B. R. J. Chemometr. 1997, 11, 339.
• [42] Daszykowski M.; Walczak B. Trends Anal. Chem. 2006, 25, 1081.
• [43] Capone S.; Epifani M.; Quaranta F.; Siciliano P.; Taurino A.; Vasanelli L. Sensor Actuat. B-Chem. 2001, 78, 174.
• [44] Mehl P. M.; Chao K.; Kim M.; Chen Y. R. Appl. Eng. Agric. 2002, 18, 219.
• [45] Smilde A.; Bro R. Multi-way Analysis with Applications in the Chemical Sciences; John Wiley & Sons: New York, USA, 2005.
• [46] AndersenC. M.; BroR. J. Chemometr. 2003, 17, 200.
• [47] Bro R.; Viereck N.; Toft M.; Toft H.; Hansen P. I.; Engelsen S. B. Trends Anal. Chem. 2010, 29, 281.
• [48] Rinnan A.; Riu J.; Bro R. J. Chemometr. 2007, 21,76.
• [49] Bro R. Chemometr. Intell. Lab. Sys. 2004, 37, 149.
• [50] Christensen J.; Becker M. B.; Frederiksen C. S. Chemometr. Intell. Lab. 2005, 75, 201.
• [51] Ebrahimi D.; Kennedy D. F.; Messerle B. A.; Hibbert D. B. Analyst 2008, 133, 817.
• [52] Van Benthem M. H.; Lane T. W.; Davis R. W.; Lane R. D.; Keenan M. R. Chemometr. Intell. Lab. 2011, 106, 115.
• [53] Amigo J. M.; Skov T.; Coello J.; Maspoch S.; Bro R. Trends Anal. Chem. 2008, 27, 714.
• [54] Kriegel H. P.; Kroger P.; Zimek A. ACM Transact. Knowl. Discov. Data 2009, 3, 1.
• [55] Draisma H. H. M.; Reijmers T. H.; Meulman J. J.; van der GreefJ.; Hankemeier T.; Boomsma D. I. Eur. J. Human Genet. 2013, 21, 95.
• [56] Morski A. Wprowadzenie do Kinetyki Chemicznej; WNT: Warszawa, Polska, 2000.

Uwagi

PL

Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2018).